vs
Side-by-side financial comparison of Greystone Housing Impact Investors LP (GHI) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $15.0M, roughly 1.9× Greystone Housing Impact Investors LP). Greystone Housing Impact Investors LP runs the higher net margin — -38.9% vs -147.1%, a 108.2% gap on every dollar of revenue. On growth, Greystone Housing Impact Investors LP posted the faster year-over-year revenue change (-33.6% vs -67.6%).
Greystone Housing Impact Investors LP is a publicly traded real estate investment partnership focused on acquiring, owning, and managing affordable and workforce multifamily housing properties across the United States. It prioritizes investments that generate stable long-term returns while expanding housing access for low and middle income communities.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
GHI vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0M | $28.1M |
| Net Profit | $-5.8M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | -33.4% | -147.6% |
| Net Margin | -38.9% | -147.1% |
| Revenue YoY | -33.6% | -67.6% |
| Net Profit YoY | -157.6% | -182.8% |
| EPS (diluted) | $-0.31 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.0M | $28.1M | ||
| Q3 25 | $21.7M | $32.5M | ||
| Q2 25 | $23.6M | $15.7M | ||
| Q1 25 | $25.1M | $8.0M | ||
| Q4 24 | $22.6M | $86.6M | ||
| Q3 24 | $24.3M | $2.1M | ||
| Q2 24 | $22.0M | $500.0K | ||
| Q1 24 | $22.4M | $0 |
| Q4 25 | $-5.8M | $-41.3M | ||
| Q3 25 | $2.0M | $-51.2M | ||
| Q2 25 | $-7.1M | $-44.9M | ||
| Q1 25 | $3.3M | $-33.9M | ||
| Q4 24 | $10.1M | $49.9M | ||
| Q3 24 | $-4.6M | $-19.1M | ||
| Q2 24 | $5.2M | $-12.5M | ||
| Q1 24 | $10.6M | $-10.3M |
| Q4 25 | -33.4% | -147.6% | ||
| Q3 25 | 9.1% | -163.7% | ||
| Q2 25 | -30.0% | -302.9% | ||
| Q1 25 | 13.2% | -466.3% | ||
| Q4 24 | 45.0% | 54.5% | ||
| Q3 24 | -19.0% | -1051.6% | ||
| Q2 24 | 23.6% | -3068.0% | ||
| Q1 24 | 47.6% | — |
| Q4 25 | -38.9% | -147.1% | ||
| Q3 25 | 9.1% | -157.4% | ||
| Q2 25 | -30.0% | -285.6% | ||
| Q1 25 | 13.2% | -425.7% | ||
| Q4 24 | 44.9% | 57.7% | ||
| Q3 24 | -19.0% | -925.0% | ||
| Q2 24 | 23.6% | -2503.2% | ||
| Q1 24 | 47.6% | — |
| Q4 25 | $-0.31 | $-0.41 | ||
| Q3 25 | $0.03 | $-0.52 | ||
| Q2 25 | $-0.35 | $-0.46 | ||
| Q1 25 | $0.11 | $-0.35 | ||
| Q4 24 | $0.38 | $0.52 | ||
| Q3 24 | $-0.23 | $-0.20 | ||
| Q2 24 | $0.19 | $-0.13 | ||
| Q1 24 | $0.42 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.5M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | — | $114.3M |
| Total Assets | $1.5B | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $39.5M | $245.0M | ||
| Q3 25 | $36.2M | $288.2M | ||
| Q2 25 | $47.5M | $240.1M | ||
| Q1 25 | $51.4M | $275.7M | ||
| Q4 24 | $14.7M | $314.0M | ||
| Q3 24 | $37.4M | $204.6M | ||
| Q2 24 | $34.0M | $218.7M | ||
| Q1 24 | $56.3M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $114.3M | ||
| Q3 25 | — | $147.7M | ||
| Q2 25 | — | $192.3M | ||
| Q1 25 | — | $229.0M | ||
| Q4 24 | — | $256.8M | ||
| Q3 24 | — | $201.0M | ||
| Q2 24 | — | $215.2M | ||
| Q1 24 | — | $223.9M |
| Q4 25 | $1.5B | $327.7M | ||
| Q3 25 | $1.5B | $372.8M | ||
| Q2 25 | $1.5B | $313.5M | ||
| Q1 25 | $1.5B | $327.3M | ||
| Q4 24 | $1.6B | $351.2M | ||
| Q3 24 | $1.5B | $217.6M | ||
| Q2 24 | $1.5B | $222.0M | ||
| Q1 24 | $1.5B | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.5M | $-43.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.5M | $-43.5M | ||
| Q3 25 | $8.4M | $-47.0M | ||
| Q2 25 | $10.2M | $-39.6M | ||
| Q1 25 | $10.3M | $-40.7M | ||
| Q4 24 | $18.0M | $42.0M | ||
| Q3 24 | $4.9M | $-14.5M | ||
| Q2 24 | $5.1M | $-7.3M | ||
| Q1 24 | $3.4M | $-6.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-39.6M | ||
| Q1 25 | — | $-40.8M | ||
| Q4 24 | — | $41.7M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-6.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | -145.4% | ||
| Q2 25 | — | -252.2% | ||
| Q1 25 | — | -512.1% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | -706.3% | ||
| Q2 24 | — | -1463.4% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 4.25× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.11× | — | ||
| Q4 24 | 1.78× | 0.84× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.32× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GHI
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
